Saturday, July 11, 2026

Drug profile · INN

zoledronic

zoledronic is a farnesyl diphosphate synthase inhibitor.

NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — zoledronic
Class
Route
Patents
0
Programs
0
Data quality
0.70

Quick answer

zoledronic is a farnesyl diphosphate synthase inhibitor.

Key facts

INN zoledronic
Mechanism Farnesyl diphosphate synthase inhibitor
Target Farnesyl pyrophosphate synthase

Mechanism of action

Farnesyl diphosphate synthase inhibitor

Primary target: Farnesyl pyrophosphate synthase

Approval history

Authority Status Date
NMPA clinical trials

Related & competitor drugs

  1. alendronate sodium Farnesyl diphosphate synthase inhibitor
  2. ibandronate sodium Farnesyl diphosphate synthase inhibitor
  3. pamidronate disodium Farnesyl diphosphate synthase inhibitor
  4. risedronate sodium Farnesyl diphosphate synthase inhibitor
  5. zoledronic acid Musculo-skeletal system (M05)
  6. alendronate sodium trihydrate Musculo-skeletal system (M05)

Frequently asked questions

What is zoledronic?

zoledronic is a farnesyl diphosphate synthase inhibitor.